These results suggest that, in SLE serum, some factors such as IFN-α and IL-6, rather than IL-10, enhance the capacity of MDDCs to stimulate allogenic T cell proliferation, while IL-10 inhibits this capacity. Here, IL10 is linked to systemic lupus erythematosus.